Activation of peroxisome proliferator-activated receptor γ by rosiglitazone inhibits lipopolysaccharide-induced release of high mobility group box 1.
about
PPAR Ligands Function as Suppressors That Target Biological Actions of HMGB1An M1-like Macrophage Polarization in Decidual Tissue during Spontaneous Preterm Labor That Is Attenuated by Rosiglitazone Treatment.HMGB1 in health and disease.Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia.Ligand-activated peroxisome proliferator-activated receptor-δ and -γ inhibit lipopolysaccharide-primed release of high mobility group box 1 through upregulation of SIRT1A Dalbergia odorifera extract improves the survival of endotoxemia model mice by inhibiting HMGB1 release.Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptorsPPAR-γ/IL-10 axis inhibits MyD88 expression and ameliorates murine polymicrobial sepsisPioglitazone reduces inflammation through inhibition of NF-κB in polymicrobial sepsis.Generation of in vivo neural stem cells using partially reprogrammed cells defective in in vitro differentiation potential.Curcumin longa extract-loaded nanoemulsion improves the survival of endotoxemic mice by inhibiting nitric oxide-dependent HMGB1 release.The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels.A novel hypothesis: up-regulation of HO-1 by activation of PPARγ inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS.Formononetin inhibits lipopolysaccharide-induced release of high mobility group box 1 by upregulating SIRT1 in a PPARδ-dependent manner.The potential signaling pathway between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha in renal interstitial fibrosis disease.
P2860
Q26738811-2C91FCB6-9B10-4208-9349-24A1F378954DQ30724406-6B419450-9556-453C-8595-53AB57165A4EQ34622835-97BDD98D-D00D-4890-A68E-AD58830698C0Q36237769-88AD1B28-9E96-4502-9440-AA130538B4E5Q36291125-66D9915B-BAE7-42C5-A230-80C1F2FB4940Q36345143-FF518896-796B-45B5-8F25-20D0DA9BC073Q36733873-4DF48196-AF7F-4653-B7DF-69D9F335E05FQ37620186-0C81442C-089C-400A-B200-41D2D091E0D1Q37637714-1F3153DB-F96E-4BF7-9524-4D03E7EA41EFQ37725454-ECBDF1A3-E0C6-475D-8967-930FD47FF378Q41722952-B39CC582-12FE-49B8-8143-87259430BA2EQ42068501-B0BBA24E-162D-4F75-969D-C2D3C1238E81Q42924090-68E682D8-CD39-431A-86C8-9CDD4EB188B1Q47220236-1444A036-4D1D-42C7-9BD4-F4AFA1F48610Q53007399-D12EEBAD-AF99-414D-8A6A-7E3FAF6C98A5
P2860
Activation of peroxisome proliferator-activated receptor γ by rosiglitazone inhibits lipopolysaccharide-induced release of high mobility group box 1.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Activation of peroxisome proli ...... of high mobility group box 1.
@ast
Activation of peroxisome proli ...... of high mobility group box 1.
@en
type
label
Activation of peroxisome proli ...... of high mobility group box 1.
@ast
Activation of peroxisome proli ...... of high mobility group box 1.
@en
prefLabel
Activation of peroxisome proli ...... of high mobility group box 1.
@ast
Activation of peroxisome proli ...... of high mobility group box 1.
@en
P2093
P2860
P356
P1476
Activation of peroxisome proli ...... e of high mobility group box 1
@en
P2093
Chankyu Park
Dae-Seog Lim
Eun Sil Kang
Han Geuk Seo
Jung Seok Hwang
Kyung Shin Paek
Sun Ah Ham
Taesik Yoo
P2860
P304
P356
10.1155/2012/352807
P50
P577
2012-12-20T00:00:00Z